ru24.pro
News in English
Июль
2024
1 2 3 4 5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

FDA approves Eli Lilly Alzheimer’s drug, expanding treatment options in the U.S.

0
CNBC 

It's a long-awaited win for Eli Lilly after donanemab faced several delays in its path to the market, including an initial rejection from the FDA last year.